Literature DB >> 6156596

A modified Warthin-Starry procedure at low pH for melanin.

R L Warkel, L G Luna, E B Helwig.   

Abstract

The Warthin-Starry argyrophilic silver stain peformed at pH 3.2 is a highly effective method for the demonstration of melanin in tissue sections. Eighty-five melanocytic tumors were studied using the Warthin-Starry and the Fontana-Masson procedures. The Warthin-Starry technic stained a greater number of cells in 68% of the tumors, with no loss of cellular detail. Twenty-three per cent of the tumors that appeared amelanotic on hematoxylin-and-eosin-stained sections were positive for melanin with the Warthin-Starry stain, but negative with the Fontana-Masson technic. The Warthin-Starry stain is more sensitive and specific for melanin than is the Fontana-Masson procedure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156596     DOI: 10.1093/ajcp/73.6.812

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Metastases of malignant melanoma simulating soft tissue sarcoma. A clinico-pathological, light- and electron microscopic and immunohistochemical study of 21 cases.

Authors:  P Lodding; L G Kindblom; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Morphology of Borrelia burgdorferi: structural patterns of cultured borreliae in relation to staining methods.

Authors:  E Aberer; P H Duray
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

3.  New, special stain for histopathological diagnosis of cryptococcosis.

Authors:  K J Kwon-Chung; W B Hill; J E Bennett
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

4.  Fractional Sunburn Threshold UVR Doses Generate Equivalent Vitamin D and DNA Damage in Skin Types I-VI but with Epidermal DNA Damage Gradient Correlated to Skin Darkness.

Authors:  Barbara B Shih; Mark D Farrar; Marcus S Cooke; Joanne Osman; Abigail K Langton; Richard Kift; Ann R Webb; Jacqueline L Berry; Rachel E B Watson; Andy Vail; Frank R de Gruijl; Lesley E Rhodes
Journal:  J Invest Dermatol       Date:  2018-05-03       Impact factor: 8.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.